Boilève, A., Dufresne, A., Chamseddine, A., Nassif, E., Dumont, S., Brahmi, M., . . . Mir, O. (2020). Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment. ESMO open, 5(6), e001082. https://doi.org/10.1136/esmoopen-2020-001082
Chicago-Zitierstil (17. Ausg.)Boilève, Alice, et al. "Outcomes of Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Treated with Multi-kinase Inhibitors Other than Imatinib as First-line Treatment." ESMO Open 5, no. 6 (2020): e001082. https://doi.org/10.1136/esmoopen-2020-001082.
MLA-Zitierstil (9. Ausg.)Boilève, Alice, et al. "Outcomes of Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Treated with Multi-kinase Inhibitors Other than Imatinib as First-line Treatment." ESMO Open, vol. 5, no. 6, 2020, p. e001082, https://doi.org/10.1136/esmoopen-2020-001082.